Five Things For Pharmacists To Know About The Treatment Of Mycobacterium Tuberculosis
IDStewardship
JUNE 19, 2025
In 2014, the US FDA approved this regimen, and it features in the latest WHO guidelines for LTBI treatment. An accessible guide encompassing key subjects in epidemiology, diagnosis, laboratory considerations, treatment, medication, co-morbidities, special circumstances, monitoring, and managing adverse reactions. 17 (2017), pp.
Let's personalize your content